Prestige BioPharma Limited

KSE:950210.KS

15930 (KRW) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2023202220212020201920182017
Assets:
Current Assets:
Cash & Cash Equivalents 219,433.241125,021.951268,650.508458,975.12345,976.249,826.4733,718.397
Short Term Investments 9,381.304176,390.4834,619.069377.6832,422.78100
Cash and Short Term Investments 228,814.545301,412.431303,269.577459,352.80648,399.0219,826.4733,718.397
Net Receivables 000001,951.3581,364.162
Inventory 18,102.9997,146.0272,156.949-155.88-2,429.64700
Other Current Assets 3,433.9682,917.1636,139.104584.0781,412.3588,254.51120.56
Total Current Assets 250,351.512311,475.621311,565.63459,936.88449,811.37920,032.3435,103.119
Non-Current Assets:
Property, Plant & Equipment, Net 327,062.419310,438.16938,342.1826,437.4624,518.7161,044.39890.493
Goodwill 10,784.68910,191.57800000
Intangible Assets 122,970.339108,719.69565,312.308109,022.98595,010.69568,267.2580
Goodwill and Intangible Assets 133,755.028118,911.27365,312.308109,022.98595,010.69568,267.2580
Long Term Investments -8,829.8-175,615.33940,090.99923,780.8576,912.8879,2816,068.22
Tax Assets 8,829.8034,619.0693,559.9122,422.78100
Other Non-Current Assets 9,381.304176,390.489,883.0411,428.3211,421.6284,298.19229,187.916
Total Non-Current Assets 461,368.951430,124.583188,247.599144,229.537110,286.70782,890.8436,146.629
Total Assets 711,720.463741,600.204499,813.229604,166.42160,098.087102,923.18341,249.748
Liabilities & Equity:
Current Liabilities:
Account Payables 2,281.993462.1482,623.8770005,340.54
Short Term Debt 48,795.66132,857.0771,593.3834,199.42443.83518,474.3996,755.539
Tax Payables 00632.3110000
Deferred Revenue 0100,024.97534,124.7563.075231.9111,710.0170
Other Current Liabilities 94,779.672101,568.82736,944.5629,847.0598,032.98113,581.5940
Total Current Liabilities 145,857.326134,888.05241,794.13314,046.4798,476.81633,766.0112,096.079
Non-Current Liabilities:
Long Term Debt 40,871.45951,516.2952,655.8763,571.3772,434.59648.11838.65
Deferred Revenue Non-Current 01,592.72225,427.36311,587.90911,387.21510,911.4421,114.499
Deferred Tax Liabilities Non-Current 7,755.3737,368.33900000
Other Non-Current Liabilities 1,734.456446.8360.0010.001010.41310.898
Total Non-Current Liabilities 50,361.28860,477.35628,083.2415,159.28713,821.81110,969.9721,164.047
Total Liabilities 196,218.614195,365.40869,877.37329,205.76522,298.62744,735.98213,260.125
Equity:
Preferred Stock 0000000
Common Stock 723,663.787690,174.731679,712.759594,071.79152,779.41961,425.63131,427.201
Retained Earnings -294,797.466-246,151.329-259,601.048-27,954.242-21,890.737-6,568.803-4,919.462
Accumulated Other Comprehensive Income/Loss -4,281.3116,511.1159,865.9388,812.9796,923.1513,330.3732.092
Other Total Stockholders Equity 14,502.4199,060.7889,824.14530.128-12.374-01,479.791
Total Shareholders Equity 439,087.428450,510.553429,935.856574,960.655137,799.45958,187.20127,989.622
Total Equity 515,501.849546,234.796429,935.856574,960.655137,799.45958,187.20127,989.622
Total Liabilities & Shareholders Equity 711,720.463741,600.204499,813.229604,166.42160,098.086102,923.18341,249.748